PASG today
$3.49-$0.51 (-12.75%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourLeaning Bearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns up above $6.30
Key levels
Resistance$4.31
Resistance$3.86
Support$3.37
Latest news & SEC filings
SEC FilingPassage BIO, Inc. filed a report on a major company event (Form 8-K)
All PASG news →About Passage BIO
Passage BIO develops gene-based treatments for neurodegenerative disorders and is still in the clinical testing phase. Its main candidate, PBFT02, uses an AAV1 vector injected into the cerebrospinal fluid to deliver a working GRN gene and boost progranulin, and is being studied in frontotemporal dementia tied to progranulin deficiency and in FTD caused by C9orf72 mutations. The company also has an early-stage Huntington's disease program under a collaboration with Gemma Biotherapeutics, and is exploring PBFT02 in ALS and Alzheimer's disease.
Based on the company's 10-K filed Mar 3, 2026.
Nasdaq · Healthcare
Passage BIO, Inc. (PASG)
What Is the Price Target for PASG?
SEPT Low Target
$7.00
SEPT Mid Target
$11.50
SEPT High Target
$30.00
Analyst Consensus
$11.50
Is PASG a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PASG.
Start Free Trial →Is PASG Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$9.52
2
Moat Score
NONE
1/9
Piotroski Score
-17.8
Altman Z-Score
What Is Smart Money Doing with PASG?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PASG Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
31.8%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for PASG
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PASG, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:06:11 | $3.49 | 2,700 | $$9K | SELL |
| 20:51:09 | $3.94 | 1,000 | $$4K | BUY |
| 16:06:53 | $3.83 | 1,000 | $$4K | SELL |
| 15:17:25 | $3.75 | 1,700 | $$6K | BUY |
| 15:17:25 | $3.75 | 3,400 | $$13K | BUY |
5 dark pool trades shown · $$36K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Passage BIO, Inc. (PASG) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PASG — frequently asked questions
What is PASG stock price today?
Passage BIO, Inc. (PASG) is at $3.49, down 12.75% (-$0.51) at the Nov 12, 2026 close.
Why is PASG stock moving today?
Latest PASG news — Nov 6, 2026: Passage BIO, Inc. filed a report on a major company event (Form 8-K)
What is the PASG price target?
The average analyst price target for PASG is $11.50, ranging from $7 to $30, based on 4 analysts. Latest: Chardan Capital downgrade on Apr 21, 2026.
What do analysts rate PASG?
Analyst ratings for PASG: 0 Buy, 3 Hold, 2 Sell — consensus Hold.
Did PASG beat earnings?
PASG last reported on Aug 10, 2026: EPS -$2.44 vs -$2.27 expected — a miss of 7.5%.
Does PASG pay a dividend?
PASG does not currently pay a dividend.
What are PASG support and resistance levels?
Support: $3.37. Resistance: $3.86, $4.31, $4.70.
What are insiders doing with PASG?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on PASG?
Nov 6, 2026: Passage BIO, Inc. filed a report on a major company event (Form 8-K)